WAVE Life Sciences (WVE) Misses Q1 EPS by 22c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.27), $0.22 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $38.6 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Akari Therapeutics adds oncology expert Patricia LoRusso to advisory board
• Cal-Maine pays $1.5M in egg price-fixing deal as executives face no charges